CUSIP 62856X300COMQCLSQ4 2025
1 filings · latest Nov 18, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 18, 2025 | Pharmacyte Biotech, Inc. | 13D/A | 74.0% | — | SEC |
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Private Advisor Group, LLC | 333.8K | $1.33M |
| 2 | Quinn Opportunity Partners LLC | 211.4K | $843.4K |
| 3 | Vanguard Group Inc | 53.1K | $211.7K |
| 4 | Jane Street Group, LLC | 40.5K | $161.5K |
| 5 | Geode Capital Management, LLC | 29.3K | $116.7K |
| 6 | Dimensional Fund Advisors LP | 19.1K | $76.0K |
| 7 | Ubs Group AG | 17.4K | $69.5K |
| 8 | Engineers Gate Manager LP | 11.3K | $45.2K |
| 9 |
| Bnp Paribas Financial Markets |
| 1.2K |
| $4.8K |
| 10 | Tower Research Capital LLC (Trc) | 235 | $938 |